{
    "id": "5e290a268b3851296d00000d",
    "question": "Is palbociclib effective for glioblastoma?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To determine the effectiveness of palbociclib for glioblastoma, let's consider what palbociclib is and its primary use. Palbociclib is a CDK4/6 inhibitor, which is a class of medications primarily used in the treatment of certain types of breast cancer, particularly HR+, HER2- advanced or metastatic breast cancer. It works by inhibiting the CDK4/6 enzymes, which play a crucial role in the progression of cancer cells. Glioblastoma, on the other hand, is a type of brain cancer that is highly aggressive and has a poor prognosis. The standard treatment for glioblastoma typically involves surgery, radiation therapy, and chemotherapy. Given the different primary use of palbociclib and the nature of glioblastoma, there is limited evidence to suggest that palbociclib is effective for glioblastoma treatment.\", \"answer_choice\": \"B\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 25.914516925811768
}